Brian Jepson reviews recent research that points to the need for greater engagement with behavioural science among medical affairs professionals, to inform medical education and engage HCPs.

Boston Scientific (NYSE: BSX) + announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer Bolt Medical. On a 100% basis — before considering an existing equity ...

Boston Scientific acquires Bolt Medical for $443 million upfront, with up to $221 million contingent on regulatory milestones. Bolt IVL platform uses acoustic waves to treat calcified artery ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The recent acquisition of Bolt Medical positions Boston Scientific strongly within the intravascular lithotripsy (IVL) space, which is considered promising due to its low penetration rates ...

Womed's cleanroom expansion, designed by Monmouth Scientific, optimizes production with ISO 7 compliance and enhanced workflow for medical device manufacturing. Sapio Sciences, the science-aware ...

When the Pistons hired former New Orleans Pelicans executive Trajan Langdon to take over for Troy Weaver, the new President of Basketball Operations wasn’t coming in to fool anybody. Langdon ...

Boston Scientific had previously held a 26% stake in the company, and said in a statement that it "initially developed the concept for the Bolt IVL system which helped establish Bolt Medical in 2019." ...